acetylcysteine has been researched along with Esophageal Squamous Cell Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, D; Guo, Y; Jia, Y; Kong, F; Lin, Z; Liu, N; Liu, Y; Peng, C; Wang, S; Zhang, L | 1 |
| Fan, X; Fang, N; Guo, M; Guo, Q; Han, Y; Liu, Z; Zhao, X; Zhu, S | 1 |
1 trial(s) available for acetylcysteine and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
Comparing N-acetylcysteine with sodium thiosulfate for relieving symptoms caused by Lugol's iodine chromoendoscopy: a randomized, double-blind trial.
Topics: Acetylcysteine; Coloring Agents; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagoscopy; Humans; Iodides; Thiosulfates | 2022 |
1 other study(ies) available for acetylcysteine and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
Downregulation of MUTYH contributes to cisplatin‑resistance of esophageal squamous cell carcinoma cells by promoting Twist‑mediated EMT.
Topics: Acetylcysteine; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Glycosylases; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Nuclear Proteins; Proteolysis; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Twist-Related Protein 1 | 2019 |